Adherence to clinic recommendations among patients with phenylketonuria in the United States

Walter, 2002, How practical are recommendations for dietary control in phenylketonuria?, Lancet, 360, 55, 10.1016/S0140-6736(02)09334-0 Vockley, 2014, Phenylalanine hydroxylase deficiency: diagnosis and management guideline, Genet. Med., 16, 188, 10.1038/gim.2013.157 Al Hafid, 2015, Phenylketonuria: a review of current and future treatments, Translat. Pediatr., 4, 304 Berry, 2013, Newborn screening 50years later: access issues faced by adults with PKU, Genet. Med., 15, 591, 10.1038/gim.2013.10 Wappner, 1999, Management of phenylketonuria for optimal outcome: a review of guidelines for phenylketonuria management and a report of surveys of parents, patients, and clinic directors, Pediatrics, 104, 10.1542/peds.104.6.e68 Trefz, 2011, Adult phenylketonuria outcome and management, Mol. Genet. Metab., 104, S26, 10.1016/j.ymgme.2011.08.025 Koch, 2002, Phenylketonuria in adulthood: a collaborative study, J. Inherit. Metab. Dis., 25, 333, 10.1023/A:1020158631102 National Institutes of Health Consensus Development P, 2001, National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16–18, 2000, Pediatrics, 108, 972, 10.1542/peds.108.4.972 MacDonald, 2012, Adherence issues in inherited metabolic disorders treated by low natural protein diets, Ann. Nutr. Metab., 61, 289, 10.1159/000342256 Agency for Healthcare Research and Quality (AHRQ), 2012, Adjuvant treatment for phenylketonuria (PKU), Comp. Eff. Rev., 56 Singh, 2014, Recommendations for the nutrition management of phenylalanine hydroxylase deficiency, Genet. Med., 16, 121, 10.1038/gim.2013.179 Freehauf, 2013, Impact of geographic access to care on compliance and metabolic control in phenylketonuria, Mol. Genet. Metab., 108, 13, 10.1016/j.ymgme.2012.09.026 Trefz, 2015, Management of adult patients with phenylketonuria: survey results from 24 countries, Eur. J. Pediatr., 174, 119, 10.1007/s00431-014-2458-4 van Spronsen, 2009, PKU-what is daily practice in various centres in Europe? Data from a questionnaire by the scientific advisory committee of the European Society of Phenylketonuria and Allied Disorders, J. Inherit. Metab. Dis., 32, 58, 10.1007/s10545-008-0966-y Ahring, 2011, Blood phenylalanine control in phenylketonuria: a survey of 10 European centres, Eur. J. Clin. Nutr., 65, 275, 10.1038/ejcn.2010.258 Gizewska, 2016, Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results, Eur. J. Pediatr., 175, 261, 10.1007/s00431-015-2622-5 Blau, 2010, Management of phenylketonuria in Europe: survey results from 19 countries, Mol. Genet. Metab., 99, 109, 10.1016/j.ymgme.2009.09.005 GMDI. Genetic Metabolic Dietitians International PKU guidelines Lee, 2005, Maternal phenylketonuria: report from the United Kingdom Registry 1978–97, Arch. Dis. Child., 90, 143, 10.1136/adc.2003.037762 Maillot, 2008, Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine, Am. J. Clin. Nutr., 88, 700, 10.1093/ajcn/88.3.700 Brown, 2016, Phenylketonuria (PKU): a problem solved?, Mol. Genet. Metab. Rep., 6, 8, 10.1016/j.ymgmr.2015.12.004